Evidence map›Paper›PMID 33079055›Full record

ArticleEmerging infectious diseases2020

KPC-3-Producing Serratia marcescens Outbreak between Acute and Long-Term Care Facilities, Florida, USA.

Adriana Jimenez, Lilian M Abbo, Octavio Martinez, Bhavarth Shukla, Kathleen Sposato, Alina Iovleva, Erin Louise Fowler, Christi Lee McElheny, Yohei Doi

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Spread of carbapenemase-producingEmerging microbes & infections · 2026
    Article
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Emergence of carbapenem-resistantMicrobiology spectrum · 2025
    Article
  5. Molecular epidemiology of a carbapenem-resistantFrontiers in microbiology · 2025
    Article
  6. Article
  7. Review
  8. The genomic characterization of carbapenem-resistantJAC-antimicrobial resistance · 2023
    Article
  9. Genomic characterization of two carbapenem-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  10. First Report ofFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adriana Jimenez
Lilian M Abbo
Octavio Martinez
Bhavarth Shukla
Kathleen Sposato
Alina Iovleva
Erin Louise Fowler
Christi Lee McElheny
Yohei Doi

Funding

Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
Study Network of Acinetobacter as a Carbapenem-Resistant Pathogen (SNAP)R21AI135522 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2018 to 2019
$460k
Mechanisms of cefiderocol resistanceR21AI151362 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2020 to 2021
$420k
NIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI135522NIAID NIH HHS R21 AI151362Wellcome Trust
6 · The paper itself

Abstract

We describe an outbreak caused by Serratia marcescens carrying bla

Indexed as

Disease OutbreaksSerratia marcescensAdultAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesFemaleFloridaHumansLong-Term CareMaleMiddle AgedNursing HomesPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesantimicrobial resistancebacteriabacterial proteinsbeta-lactamasecarbapenemasecarbapenem-resistant EnterobacteriaceaeCPEdisease outbreaksFloridainfection controlinfectionsKlebsiella pneumoniae carbapenemaseKPCKPC-3long-term careSerratia marcescensUnited States

Identifiers

PMID33079055
PMCPMC7588513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.